Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Arrhythmias

Free Subscription 15.09.2025 2 Am J Emerg Med 1 Ann Emerg Med 1 Ann Intern Med 1 Circ Genom Precis Med 2 Circulation 1 Clin Cardiol 6 Eur Heart J 2 Heart 5 Int J Cardiol 1 J Am Coll Cardiol 31 J Cardiovasc Electrophysiol 2 J Electrocardiol 2 J Interv Card Electrophysiol 1 J Thorac Cardiovasc Surg 3 Pacing Clin Electrophysiol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Emerg Med

1. KAWJI MM
   Reader comment regarding "[Electrocardiogram essentials: Bradycardia]".
   Am J Emerg Med. 2025 Sep 2:S0735-6757(25)00607.
   PubMed        
   
   
2. TANNENBAUM L, Long B
   The Authors Respond to Reader Comment Regarding [Electrocardiogram essentials: Bradycardia].
   Am J Emerg Med. 2025 Sep 2:S0735-6757(25)00606.
   PubMed        
   
   

   
   Ann Emerg Med

3. ATZEMA CL, Healey JS
   Opportunistic Detection of Atrial Fibrillation in the Emergency Department: Today's Health Care Systems Are Not Prepared to Reap the Benefits.
   Ann Emerg Med. 2025 Sep 10:S0196-0644(25)01137.
   PubMed        
   
   

   
   Ann Intern Med

4. CENTOR RM, Zimetbaum P
   Annals On Call - Atrial Fibrillation: When Ablation Is the Way to Go.
   Ann Intern Med. 2025 Sep 2:e2503841OC. doi: 10.7326/ANNALS-25-03841.
   PubMed        
   
   

   
   Circ Genom Precis Med

5. CHEN Z, Aziz P, Greenland P, Passman R, et al
   Age-Dependent Contributions of Rare and Common Genetic Variation in Atrial Fibrillation.
   Circ Genom Precis Med. 2025 Sep 11:e004958. doi: 10.1161/CIRCGEN.124.004958.
   PubMed         Abstract available
   
   

   
   Circulation

6. SOHNS C, Moersdorf M, Marrouche NF, Costard-Jaeckle A, et al
   3-Year Outcomes of Catheter Ablation in Patients with End-Stage Heart Failure and Atrial Fibrillation.
   Circulation. 2025 Aug 31. doi: 10.1161/CIRCULATIONAHA.125.075787.
   PubMed        
   
   
7. OLDGREN J, Hijazi Z, Arheden H, Bjorkenheim A, et al
   Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study.
   Circulation. 2025 Aug 30. doi: 10.1161/CIRCULATIONAHA.125.076725.
   PubMed         Abstract available
   
   

   
   Clin Cardiol

8. JAVED A, Savez SM, Rayyan SM
   Critique on "Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification".
   Clin Cardiol. 2025;48:e70207.
   PubMed        
   
   

   
   Eur Heart J

9. VERMEER J, Vinck-de Greef T, van den Broek M, de Louw B, et al
   Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial.
   Eur Heart J. 2025 Aug 30:ehaf689. doi: 10.1093.
   PubMed         Abstract available
   
   
10. HESSELLUND AK, Kongebro EK, Haugan KJ, Graff C, et al
    Hypokalaemia and atrial fibrillation detected by implanted loop recorders.
    Eur Heart J. 2025 Aug 30:ehaf623. doi: 10.1093.
    PubMed         Abstract available
    
    
11. LINZ D, Chaldoupi SM
    Hypokalaemia in atrial fibrillation: a red flag for more comprehensive workup?
    Eur Heart J. 2025 Aug 30:ehaf651. doi: 10.1093.
    PubMed        
    
    
12. NIMANI S, Bains S, Alerni N, Ordog B, et al
    AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.
    Eur Heart J. 2025 Aug 30:ehaf660. doi: 10.1093.
    PubMed         Abstract available
    
    
13. YUAN X, Ju F, Wu H, Zhao Y, et al
    Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial.
    Eur Heart J. 2025 Sep 1:ehaf674. doi: 10.1093.
    PubMed         Abstract available
    
    
14. FAKUADE FE, Gronwald J, Brandes P, Doring Y, et al
    Cytosolic calcium handling signature: integration with clinical predictors enhances prediction of post-operative atrial fibrillation.
    Eur Heart J. 2025 Sep 9:ehaf609. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

15. CHO MS, Kang DY, Lee JB, Oh YS, et al
    Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial.
    Heart. 2025 Sep 9:heartjnl-2025-326646. doi: 10.1136/heartjnl-2025-326646.
    PubMed         Abstract available
    
    
16. WILNES B, Castello-Branco B, Santangeli P
    ECG algorithms for localisation of outflow tract ventricular arrhythmias: is there a winner?
    Heart. 2025 Sep 3:heartjnl-2025-326550. doi: 10.1136/heartjnl-2025-326550.
    PubMed        
    
    

    
    Int J Cardiol

17. SHAWKI M, Sampaio Rodrigues T, Khabazi KP, Brick C, et al
    Short-term incidence and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy receiving cardiac myosin inhibitors: A systematic review and meta-analysis.
    Int J Cardiol. 2025;442:133846.
    PubMed         Abstract available
    
    
18. VELT MJH, Mulder BA
    Reply to letters to the editor part 2: Duration of atrial fibrillation and cardiac biomarkers: Data from the RACE II study.
    Int J Cardiol. 2025 Sep 1:133850. doi: 10.1016/j.ijcard.2025.133850.
    PubMed        
    
    
19. VELT MJH, Mulder BA
    Reply to letters to the editor part 1: Duration of atrial fibrillation and cardiac biomarkers: Data from the RACE II study.
    Int J Cardiol. 2025 Sep 2:133849. doi: 10.1016/j.ijcard.2025.133849.
    PubMed        
    
    
20. LU Y, Liu Y, Zhang Y, Wang H, et al
    Global burden of early-onset atrial fibrillation and flutter: Population based study.
    Int J Cardiol. 2025 Sep 6:133862. doi: 10.1016/j.ijcard.2025.133862.
    PubMed         Abstract available
    
    
21. HINOJOSA W, Velazquez-Martin M, Coronel ML, Segura de la Cal T, et al
    Prognostic value of longitudinal QTc interval analysis in pulmonary arterial hypertension.
    Int J Cardiol. 2025;441:133816.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

22. HAMMERSLEY DJ, McDonagh TA, Prasad SK
    Bridging the Gap Between Atrial Fibrillation, Cardiomyopathy and Prognosis: Does Genetics Hold the Key?
    J Am Coll Cardiol. 2025;86:754-756.
    PubMed        
    
    

    
    J Cardiovasc Electrophysiol

23. SANTORO F, D'Apolito M, Ragnatela I, Ranaldi A, et al
    Caveolin 3 Variant T78M in a Large Family With Brugada Syndrome: Clinical Features and Coexistence of ADRB1 and GRK5 Gene Mutation.
    J Cardiovasc Electrophysiol. 2025;36:2132-2139.
    PubMed         Abstract available
    
    
24. ALLAM L, Bekouti JT, Gabra MD, Shogade TT, et al
    Clinical Profile and Management of Wolf-Parkinson White Syndrome and Asymptomatic Pre-Excitation Carriers in Africa: A Multicenter Pan African Registry From 17 Countries.
    J Cardiovasc Electrophysiol. 2025;36:2117-2131.
    PubMed         Abstract available
    
    
25. EJIMA K
    Microembolic Signals During Atrial Fibrillation Ablation: Is the Thing That Catches the Eye the Real Villain? or Is It Innocent and Insignificant?
    J Cardiovasc Electrophysiol. 2025 Sep 11. doi: 10.1111/jce.70104.
    PubMed        
    
    
26. PURI P, Moe D, Alzahrani A, Goldar G, et al
    Trends in Atrial Fibrillation Ablation Utilization Following 2022 CMS Reimbursement Reduction: A Nationwide Analysis.
    J Cardiovasc Electrophysiol. 2025 Sep 9. doi: 10.1111/jce.70102.
    PubMed         Abstract available
    
    
27. MARIANI MV, Matteucci A, Pierucci N, Palombi M, et al
    Reply To: Bayesian Evaluation of Pentaspline Pulsed Field Ablation Compared to High-Power Radiofrequency Ablation in Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2025 Sep 9. doi: 10.1111/jce.70103.
    PubMed        
    
    
28. SCHEID M, Coleman KM, Mullane S, Varrias D, et al
    Leveraging Implantable Cardiac Defibrillator Remote Transmissions to Predict the Occurrence of Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2025 Sep 7. doi: 10.1111/jce.70072.
    PubMed         Abstract available
    
    
29. COSTA AD, Benali K
    The Never Old-Fashioned Right Atrial Flutter Revisited.
    J Cardiovasc Electrophysiol. 2025 Sep 7. doi: 10.1111/jce.70082.
    PubMed        
    
    
30. HASHIM U, Patel R, Demo H, Fisher W, et al
    Patient Comfort and Response Pattern Following Pulsed-Field Ablation Compared to Radiofrequency Ablation for Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2025 Sep 4. doi: 10.1111/jce.70077.
    PubMed         Abstract available
    
    
31. PHILLIPS KP
    Expanding Access to Atrial Fibrillation Interventions: Patient Safety Must Remain the Priority.
    J Cardiovasc Electrophysiol. 2025 Sep 3. doi: 10.1111/jce.70094.
    PubMed        
    
    
32. SOHAIL S, Ahmed N, Rana MA, Abbas MH, et al
    Challenges to the Claimed Safety and Feasibility of Atrial Fibrillation Ablation and Left Atrial Appendage Occlusion Without Onsite Cardiothoracic Surgery.
    J Cardiovasc Electrophysiol. 2025 Sep 3. doi: 10.1111/jce.70093.
    PubMed        
    
    
33. SALEIRO C, Barra S, Oliveiros B, Alves P, et al
    Ethanol Infusion in the Vein of Marshall for Persistent Atrial Fibrillation Ablation: Evidence From Randomized Controlled Trials.
    J Cardiovasc Electrophysiol. 2025 Sep 3. doi: 10.1111/jce.70090.
    PubMed         Abstract available
    
    
34. YETIM M, Sarihan A, Kalcik M
    Limitations and Challenges of Three-Dimensional Echocardiography in Predicting Atrial Fibrillation Recurrence.
    J Cardiovasc Electrophysiol. 2025 Sep 3. doi: 10.1111/jce.70095.
    PubMed        
    
    
35. XU Y, Zhao Z, Xu H, Jiang C, et al
    Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome.
    J Cardiovasc Electrophysiol. 2025 Sep 3. doi: 10.1111/jce.70073.
    PubMed         Abstract available
    
    
36. YANG X
    Letter to the Editor: Anticoagulation Risk Stratification and Methodological Considerations in Immediate Mobilization After Atrial Fibrillation Ablation.
    J Cardiovasc Electrophysiol. 2025 Sep 3. doi: 10.1111/jce.70088.
    PubMed        
    
    
37. CABRAL DCBI, Rivera A, Braga MAP, Passos BMF, et al
    High-Power Short-Duration Ablation Versus Conventional Power Ablation in Pulmonary Vein Isolation in Patients With Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Cardiovasc Electrophysiol. 2025 Aug 31. doi: 10.1111/jce.16735.
    PubMed         Abstract available
    
    
38. DENYSIUK P, Szczasny M, Blaszczak P
    Wave Speed Mapping as a Complementary Tool for Identifying Ventricular Tachycardia Substrate.
    J Cardiovasc Electrophysiol. 2025;36:2452-2457.
    PubMed         Abstract available
    
    
39. KRANERT M, Scheckenbach C, Harm T, Gawaz M, et al
    Pulsed-Electrical Field Ablation Completes Pulsed-Field Ablation-Lessons Learned on Tissue Proximity Indication in Pulmonary Vein Isolation.
    J Cardiovasc Electrophysiol. 2025;36:2445-2448.
    PubMed         Abstract available
    
    
40. RAINA A, Mulpuru SK, DeSimone CV
    Novel Subxiphoid Cut Down Approach to Facilitate Epicardial Catheter Ablation in an Obese Patient.
    J Cardiovasc Electrophysiol. 2025;36:2440-2444.
    PubMed         Abstract available
    
    
41. YAGYU K, Oginosawa Y, Kobayashi T, Nakamura Y, et al
    The Single-Delayed-Phase Contrast Computed Tomography Before Ablation to Reduce Radiation Exposure Without Compromising Diagnostic Pulmonary Vein Accuracy.
    J Cardiovasc Electrophysiol. 2025;36:2341-2352.
    PubMed         Abstract available
    
    
42. STRAZDAS A, Tijskens M, Abugattas JP, Wolf M, et al
    Adding Non-Occlusive Cryoballoon Ablation in Case of Ostial-Level Pulmonary Vein Isolation or Carina Sparing Does Not Improve 1-Year Outcome After Cryoballoon Ablation (the NOCA-AF Study).
    J Cardiovasc Electrophysiol. 2025;36:2330-2340.
    PubMed         Abstract available
    
    
43. SORENSEN SK, Riis-Vestergaard LD, Tonnesen J, Johannessen A, et al
    Durability of Pulmonary Vein Isolation With the Heliostar Radiofrequency Balloon-The Prospective RABAAF Study With Protocol-Mandated Repeat Electrophysiology Studies.
    J Cardiovasc Electrophysiol. 2025;36:2320-2329.
    PubMed         Abstract available
    
    
44. EL ASSAAD I, Heilbronner AK, Zahka K, Hammond B, et al
    Utility of Cardiopulmonary Exercise Testing in Assessing Beta-Blocker Efficacy in LQTS: Moving Away From One-Size-Fits-All.
    J Cardiovasc Electrophysiol. 2025;36:2287-2295.
    PubMed         Abstract available
    
    
45. DINA A, Demchuk K, Koulouridis I, Dutta R, et al
    Procedural Outcomes and Conduction System Capture Pattern Maintenance With the Tendril STS 2088TC Lead and CPS Locator 3D Delivery System: A Comparative Analysis With Lumenless Lead System.
    J Cardiovasc Electrophysiol. 2025;36:2296-2303.
    PubMed         Abstract available
    
    
46. GUPTA K, Qureshi MA, Rawlley B, Jain V, et al
    Effectiveness and Safety of Intramyocardial Needle Ablation for Refractory Ventricular Tachycardia and Premature Ventricular Complexes: A Systematic Review and Meta-Analysis.
    J Cardiovasc Electrophysiol. 2025;36:2279-2286.
    PubMed         Abstract available
    
    
47. GEMESI M, Polgar B, Gingl Z, Marczell I, et al
    Kinetics and Disappearance of QRS Transition in Patients Undergoing Left Bundle Branch Pacing - A Novel Method for Classifying Microdislodgement.
    J Cardiovasc Electrophysiol. 2025;36:2254-2263.
    PubMed         Abstract available
    
    
48. ATTA S, Aboelhassan M, Ibraheem MK, Taha S, et al
    Accessory Pathway Antegrade Electrophysiologic Features Among Wolff-Parkinson-White Patients: The Risk in Relation to the Location.
    J Cardiovasc Electrophysiol. 2025;36:2264-2270.
    PubMed         Abstract available
    
    
49. SAGOO NS, Sagoo R, Srinivasaraghavan A, Bose G, et al
    Impact of Advanced Age on In-Hospital Outcomes Following Leadless Pacemaker Implantation.
    J Cardiovasc Electrophysiol. 2025;36:2151-2159.
    PubMed         Abstract available
    
    
50. TOKAVANICH N, Alaka A, Tye M, Chakrabarti A, et al
    Improvement in Mitral Regurgitation After Catheter Ablation of Premature Ventricular Complexes.
    J Cardiovasc Electrophysiol. 2025;36:2188-2195.
    PubMed         Abstract available
    
    
51. MOSTAFA MA, Bodziock G, Cotten L, Schaich CL, et al
    Exploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non-Actionable Alerts and Assessing Clinical Outcomes.
    J Cardiovasc Electrophysiol. 2025;36:2226-2232.
    PubMed         Abstract available
    
    
52. BANAI A, Dukkipati S, Watanbe K, Shinohara M, et al
    Endocardial Atrial Lesion Characteristics With Pentaspline Pulsed Field Ablation: Insights From Serial Mapping in Patients.
    J Cardiovasc Electrophysiol. 2025;36:2179-2187.
    PubMed         Abstract available
    
    
53. CHOKR MO, Filho HHR, Coello RA, Kulchetscki RM, et al
    Long-Term Follow-Up of Inducible Bundle Branch Reentrant Ventricular Tachycardia in Patients Without Structural Heart Disease: Beyond the Electrophysiology Laboratory.
    J Cardiovasc Electrophysiol. 2025;36:2140-2150.
    PubMed         Abstract available
    
    

    
    J Electrocardiol

54. KAPLAN E, Ekizler FA, Saribas H, Tufekcioglu O, et al
    Interatrial block predicts left atrial appendage thrombus in nonvalvular atrial fibrillation.
    J Electrocardiol. 2025;93:154112.
    PubMed         Abstract available
    
    
55. RAJENDRAN K, Alphonse AJ, Desabandhu V
    An elderly woman with bradycardia and progressive repolarization abnormalities.
    J Electrocardiol. 2025;93:154109.
    PubMed         Abstract available
    
    

    
    J Interv Card Electrophysiol

56. MATSUMOTO K, van Bragt KA, Kueffer FJ, Mburu W, et al
    Indirect treatment comparison of two pulsed field ablation systems for the treatment of persistent atrial fibrillation.
    J Interv Card Electrophysiol. 2025 Sep 10. doi: 10.1007/s10840-025-02124.
    PubMed         Abstract available
    
    
57. ALFRED J, Mastella G, Rattka I, Jurik N, et al
    Comparison of artificial intelligence-adjudicated spatiotemporal dispersion in spontaneous vs. induced atrial fibrillation among patients with persistent AF.
    J Interv Card Electrophysiol. 2025 Sep 8. doi: 10.1007/s10840-025-02122.
    PubMed        
    
    

    
    J Thorac Cardiovasc Surg

58. PAPARELLA D, Belley-Cote EP, Di Mauro M, Squiccimarro E, et al
    Oral anticoagulation in patients with atrial fibrillation and heart valve prosthesis: a substudy from the LAAOS III Trial.
    J Thorac Cardiovasc Surg. 2025 Sep 8:S0022-5223(25)00763.
    PubMed         Abstract available
    
    

    
    Pacing Clin Electrophysiol

59. SHODA M, Imamura K, Takami M, Fukuzawa K, et al
    Bradycardia-Dependent Transient Rise in the Atrial Lead Capture Threshold 21 Years After the Lead Implantation.
    Pacing Clin Electrophysiol. 2025 Sep 11. doi: 10.1111/pace.70041.
    PubMed         Abstract available
    
    
60. PALMISANO P, Palama Z, Bartorelli AL, Bonanno S, et al
    Risk of Symptomatic Pulmonary Vein Stenosis After Atrial Fibrillation Ablation With High-Power Short-Duration Approach.
    Pacing Clin Electrophysiol. 2025 Sep 11. doi: 10.1111/pace.70040.
    PubMed         Abstract available
    
    
61. NANTSUPAWAT T, Li Y, Li S, Sathnur N, et al
    Addition of Atrial Myopathy to HATCH Score for Predicting New-Onset Atrial Fibrillation After Ablation of Atrial Flutter.
    Pacing Clin Electrophysiol. 2025 Sep 11. doi: 10.1111/pace.70044.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.